Aardvark Therapeutics, Inc.
(AARD)Financial Statements · SEC EDGAR XBRL
Net Income
-$57.6M
-179.7%
EPS
$-2.93
+43.1%
Op. Income
-$62.7M
-175.3%
FCF
-$54.3M
-198.2%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Operating Expenses & Income
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)